J&J



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.18B 486M 2025-03
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Baxter International USD 576M 116M 2024-12
Bayer EUR 3.59B 1.92B 2025-03
Becton, Dickinson and Co. USD 1.39B 138M 2025-03
Biogen USD 754.8M 7.2M 2024-12
Boston Scientific USD 1.36B 16M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
CONMED USD 39.5M 31M 2025-03
Cooper Companies USD 243.8M 45.6M 2025-01
Dexcom USD 193.7M 111.6M 2025-03
Edwards Lifesciences USD 411.3M 15.3M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Globus Medical USD 164.2M 18.87M 2025-03
Hologic USD 307.3M 19.1M 2025-03
Indivior 72M 34M 2025-03
Insulet USD 110.5M 20.3M 2025-03
Integra LifeSciences USD 63.87M 41.11M 2025-03
Intuitive Surgical USD 581.5M 168M 2025-03
J&J USD 7.88B 1.76B 2025-03
Medtronic USD 2.7B 267M 2025-04
Merck USD 7.74B 625M 2025-03
Merit Medical Systems USD 73.31M 3.35M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Stryker USD 1.42B 519M 2025-03
Tandem Diabetes Care USD -30183000 33.85M 2025-03
Teva Pharmaceutical Industries USD 1.11B 848M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Zimmer Biomet Holdings USD 709.4M 138.6M 2024-12
Zoetis USD 968M 74M 2025-03



J&J - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.